Trademark: TIME T2D DISRUPT 1711649
Word
TIME T2D DISRUPT
Device Descrption:
PIPE THRU LTRS
ID
1711649
Trademark Type
Figurative
Status
Registered: Registered/protected
Application Date
03 August 2015
Registration Date
03 August 2015
Renewal Date
03 August 2025
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 5:
Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases/disorders
Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases/disorders
Class 10:
Drug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders
Drug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders
Class 41:
Development and dissemination of educational materials of others in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of diabetes, obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith
Development and dissemination of educational materials of others in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of diabetes, obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith
Class 42:
Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; medical and scientific research in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals
Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; medical and scientific research in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals
Class 44:
Medical information services, namely, providing information on the topics of diabetes, obesity, and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, pharmaceuticals, clinical trials, drug delivery technologies, and administration of pharmaceuticals
Medical information services, namely, providing information on the topics of diabetes, obesity, and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, pharmaceuticals, clinical trials, drug delivery technologies, and administration of pharmaceuticals